Ibrutinib and Palbociclib in Treating Patients With Previously Treated Mantle Cell Lymphoma
Clinical trial NCT02159755 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02159755
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-13
- Primary completion
- 2018-06-25
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.